Newstral
Article
Reuters on 2019-08-21 12:33
Schweizer Augenheilkonzern Alcon verfehlt Renditeziel
Related news
- Trennung von Novartis kommt Augenheilkonzern Alcon teuer zu stehenReuters
- Augenheilkonzern Alcon rutscht operativ in die roten ZahlenReuters
- Schweizer Börse rückt weiter vor - Lonza und Alcon gefragtReuters
- Novartis Considers Alcon Spin-OffForbes
- Siemens Healthineers verfehlt Renditeziel - Dividende soll steigenReuters
- Struggling Alcon shows some progress as Novartis weighs spinoffStar Telegram
- Alcon feiert Mega-Börsendebüt - Eisbrecher in Europa?Reuters
- Pharmakonzern Novartis treibt Alcon-Börsengang voranReuters
- Alcon targeted in $110M gender discrimination lawsuitbizjournals.com
- Novartis slims down with $25bn spin-off of Alcon eyecare businessbusinessdayonline.com
- Novartis says 'never say never' to Alcon disposalReuters
- Novartis launches $5 billion share buyback, mulls Alcon spin-offReuters
- Novartis open global data center at Alcon in Fort WorthStar Telegram
- Former Alcon CEO honored for philanthropy, community good deedsStar Telegram
- Fort Worth eye products firm Alcon shifting headquarters to SwitzerlandDallas News
- Former Alcon employees sue company for gender and pay discriminationStar Telegram
- Alcon shifting global HQ from Fort Worth to Genevabizjournals.com
- TAnalyse: Alcon: was es für eine Fortsetzung der Aktienkursrally brauchtthemarket.ch
- Fort Worth’s Alcon spun off Novartis, now trading on NYSEStar Telegram
- BNP Paribas senkt RenditezielReuters